Healthcare provider profile · identity verified

Dharmesh K Shah, MD

Family Practice · CHESAPEAKE, VA · NPI 1942264775

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	301	72
Metformin Hcl	Metformin Hcl	191	53
Levothyroxine Sodium	Levothyroxine Sodium	190	55
Atorvastatin Calcium	Atorvastatin Calcium	184	55
Montelukast Sodium	Montelukast Sodium	143	33
Rosuvastatin Calcium	Rosuvastatin Calcium	134	38
Simvastatin	Simvastatin	127	36
Hydrochlorothiazide	Hydrochlorothiazide	122	33
Losartan Potassium	Losartan Potassium	104	33
Metoprolol Succinate	Metoprolol Succinate	103	25
Gabapentin	Gabapentin	97	23
Tamsulosin Hcl	Tamsulosin Hcl	96	21
Fluticasone Propionate	Fluticasone Propionate	80	28
Omeprazole	Omeprazole	79	25
Eliquis	Apixaban	77	13
Pravastatin Sodium	Pravastatin Sodium	72	17
Hydralazine Hcl	Hydralazine Hcl	64	18
Donepezil Hcl	Donepezil Hcl	61	suppressed
Furosemide	Furosemide	60	22
Lorazepam	Lorazepam	55	29
Albuterol Sulfate Hfa	Albuterol Sulfate	54	16
Mirtazapine	Mirtazapine	52	15
Potassium Chloride	Potassium Chloride	52	16
Tramadol Hcl	Tramadol Hcl	52	11
Allopurinol	Allopurinol	50	suppressed
Prednisone	Prednisone	49	27
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	48	15
Finasteride	Finasteride	48	12
Lisinopril	Lisinopril	48	18
Metoprolol Tartrate	Metoprolol Tartrate	48	suppressed
Synthroid	Levothyroxine Sodium	46	13
Citalopram Hbr	Citalopram Hydrobromide	44	11
Trazodone Hcl	Trazodone Hcl	42	15
Spironolactone	Spironolactone	41	15
Bumetanide	Bumetanide	38	12
Pantoprazole Sodium	Pantoprazole Sodium	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Carvedilol	Carvedilol	35	12
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Jardiance	Empagliflozin	33	suppressed
Acarbose	Acarbose	31	suppressed
Meloxicam	Meloxicam	31	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Alprazolam	Alprazolam	28	suppressed
Azithromycin	Azithromycin	28	15
Ezetimibe	Ezetimibe	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	20
Sertraline Hcl	Sertraline Hcl	27	suppressed
Colchicine	Colchicine	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Atenolol	Atenolol	22	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Valsartan	Valsartan	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Famotidine	Famotidine	21	suppressed
Glipizide	Glipizide	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Haloperidol Lactate	Haloperidol Lactate	20	17
Memantine Hcl	Memantine Hcl	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Amoxicillin	Amoxicillin	19	11
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Linzess	Linaclotide	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	18
Clonidine	Clonidine	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Nadolol	Nadolol	17	suppressed
Ozempic	Semaglutide	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Moexipril Hcl	Moexipril Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Cephalexin	Cephalexin	13	suppressed
Dexamethasone	Dexamethasone	13	suppressed
Diazepam	Diazepam	13	suppressed
Estradiol	Estradiol	13	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Letrozole	Letrozole	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Nystatin	Nystatin	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error